AI-Crafted Universal Coronavirus Vaccine Clears First Human Trial
TL;DR
An AI-designed universal coronavirus vaccine completed a Phase 1 trial in 39 healthy adults, showing a 100% safety profile and robust immune responses against diverse coronaviruses. Delivered via a needle-free microfluidic DNA platform, the vaccine targets conserved viral core features rather than mutable surface spikes, signaling a potential shift from variant boosters to a single broad defense. If Phase 2 confirms durability and broad protection, the approach could reshape vaccine design and public health logistics, including reduced cold-chain needs and biomedical waste.
- Breakthrough: Universal Coronavirus Vaccine Designed By AI Passes Human Trial NDTV
- 'World-first' vaccine designed by artificial intelligence BBC
- AI-designed universal coronavirus vaccine passes first human trial ScienceDaily
- The University of Cambridge says it successfully tested a vaccine with an AI-designed antigen Engadget
- AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery Medical Xpress
Want the full story? Read the original reporting
Read on NDTV